Pharmaceutical Outsourcing magazine is entering an exciting new phase as it transitions to a digital-only edition, reinforcing its commitment to delivering timely, accessible, and high-impact content to the global pharmaceutical outsourcing community.
This evolution reflects the changing ways industry professionals consume information today—favoring on-demand access, mobile-friendly formats, and richer multimedia experiences that extend beyond the limitations of traditional print cycles.
“Our audience has always been at the center of every decision we make,” said Tom Neely, Associate Publisher. “This move allows us to deliver more dynamic, responsive, and engaging content while meeting readers where they are—online, in real time, and across multiple devices.”
The digital-only format will enable Pharmaceutical Outsourcing to expand coverage and enhance storytelling through interactive features, embedded video, data visualizations, and faster publication timelines. Readers will benefit from more frequent updates, improved searchability, and seamless access to content across desktop, tablet, and mobile platforms.
For advertisers and partners, the shift unlocks new opportunities for integrated campaigns, including richer ad formats, performance tracking, and enhanced audience targeting. Brands will be able to connect with a highly engaged, specialized audience of outsourcing, manufacturing, and pharmaceutical development professionals through more flexible and measurable digital solutions.
Importantly, this transition builds on the publication’s long-standing legacy of trusted editorial coverage in the pharmaceutical outsourcing space. The commitment to high-quality reporting, industry insight, and thought leadership remains unchanged—now delivered in a more agile and scalable format designed for today’s fast-moving environment.
The move also supports broader sustainability goals by reducing reliance on print production while continuing to maximize the publication’s reach and influence across the global pharma outsourcing community.
Subscribers and readers will continue to receive full access to all content through the digital edition, email newsletters, and expanded online channels. No action is required to maintain access.
Pharmaceutical Outsourcing remains dedicated to serving as a leading resource for professionals navigating the evolving landscape of pharmaceutical development and manufacturing partnerships.